Nora Pashayan (@norapashayan) 's Twitter Profile
Nora Pashayan

@norapashayan

Public health doctor | Prof @Cambridge_Uni| Hon Prof @UCL | Research in cancer screening | views mine / RTs not endorsement

ID: 571144414

linkhttps://iris.ucl.ac.uk/research/personal?upi=NPASH45 calendar_today04-05-2012 20:53:01

401 Tweet

367 Takipçi

401 Takip Edilen

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

📢 Job opportunity Come join me as a postdoc researcher Cambridge University working on stochastic modelling for cancer screening. Application closing on 13th August. To apply jobs.cam.ac.uk/job/41966/

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

Artsakh Peace Festival, virtual platform of classical musicians united to open the Road of Life to Artsakh m.youtube.com/@ArtsakhPeaceF…

Chris Jackson (@cjackstats) 's Twitter Profile Photo

If you like multistate / survival modelling you may be interested in this position jobs.cam.ac.uk/job/41966/ collaborating with some good people in a neighbouring department.

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

12 recommendations to improve representation of minoritised groups in research in cancer #earlydetection nature.com/articles/s4141… by the #ACED funded REPRESENT group

Paul Pharoah (R soul) 🇪🇺🇵🇬🇿🇦🇬🇧 (@paulpharoah) 's Twitter Profile Photo

Just to remind you why we do (ovarian) cancer research, here are some patient stories from patients and the CRUKCambridge Ovarian Programme. crukcambridgecentre.org.uk/news/ovarian-c…

Antonis Antoniou (@antonis02) 's Twitter Profile Photo

We’re looking for a (senior) research associate to assist building the Science and Innovation at Cancer Research UK Cancer Data Driven Detection #CD3 initiative. An expert in health data science? Check out this exciting & flexible opportunity Cambridge University jobs.cam.ac.uk/job/43687/ Closes 8 Nov #epitwitter

Dr Chiara Herzog (@chiara_herzog) 's Twitter Profile Photo

🔬New findings on breast cancer risk prediction: our study in npj Precision Oncology reveals the power of epigenetics in understanding risk, focusing genetic X nonheritable factors captured on the epigenome in the "right" surrogate sample 🧬 👉 doi.org/10.1038/s41698…

Prostate Cancer UK (@prostateuk) 's Twitter Profile Photo

Introducing the TRANSFORM trial. A £42 million research programme, led and developed by us and backed by £16 million of government funding. It's the biggest and most ambitious prostate cancer trial in 20 years. 👉 Find out more: bit.ly/3SInU51

Introducing the TRANSFORM trial.  

A £42 million research programme, led and developed by us and backed by £16 million of government funding.  

It's the biggest and most ambitious prostate cancer trial in 20 years. 

👉 Find out more: bit.ly/3SInU51
Paul Pharoah (R soul) 🇪🇺🇵🇬🇿🇦🇬🇧 (@paulpharoah) 's Twitter Profile Photo

1/n An all new version of PREDICT breast is now live at breast.v3.predict.cam Thanks to Alexandra Freeman, Mehdi Hajjam, @ProfWishart, David Spiegelhalter and Isabelle Grootes. V2.2 still available at breast.predict.cam. Major changes are....

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

We’re looking for a research associate to develop simulation models for evaluating cancer early detection. An expert in stochastic modelling? Check out this exciting opportunity Cambridge University jobs.cam.ac.uk/job/47297/

Siddhartha Kar (@siddhartha_kar) 's Twitter Profile Photo

📢 In print this week on the role of polygenic risk scores in cancer screening 👇 thelancet.com/journals/lance… Co-authored with rising ⭐ clinical academic Sarah Perrott, who recently completed the research rotation of her specialised foundation programme with us at Early Cancer Institute, University of Cambridge

📢 In print this week on the role of polygenic risk scores in cancer screening 👇

thelancet.com/journals/lance…

Co-authored with rising ⭐ clinical academic <a href="/perrott_sarah/">Sarah Perrott</a>, who recently completed the research rotation of her specialised foundation programme with us at <a href="/EarlyCancerCam/">Early Cancer Institute, University of Cambridge</a>
Antonis Antoniou (@antonis02) 's Twitter Profile Photo

Latest publication from the group on evaluating the performance of CanRisk / BOADICEA canrisk.org in predicting ovarian cancer risk Paper: nature.com/articles/s4141… Thread by Xin 👇

Paul Pharoah (R soul) 🇪🇺🇵🇬🇿🇦🇬🇧 (@paulpharoah) 's Twitter Profile Photo

1/2 We have previously developed a method for generating a poygenic model using summary statistics - called S4. We have compared S4 with LDPred2 for 12 different phenotypes as well as developing a composite S4+LDPred2 method. link.springer.com/10.1186/s12864…

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

Applications for the ACED 4-Year PhD Studentship at are now open!! Deadline Monday 4th November 2024. Further details earlycancer.cam.ac.uk/aced-phd-stude…

Early Cancer Institute, University of Cambridge (@earlycancercam) 's Twitter Profile Photo

🙌Hands up if you're a highly motivated and talented scientist looking for a unique, multi-disciplinary training programme in cancer early detection?🙌 Apply for the ACED 4-year #PhD Studentship by 4th Nov 2024 and you could be joining our amazing team! earlycancer.cam.ac.uk/aced-phd-stude…

🙌Hands up if you're a highly motivated and talented scientist looking for a unique, multi-disciplinary training programme in cancer early detection?🙌
Apply for the ACED 4-year #PhD Studentship by 4th Nov 2024 and you could be joining our amazing team!
earlycancer.cam.ac.uk/aced-phd-stude…
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer (BARCODE1) out on NEJM nejm.org/doi/full/10.10… Study evaluated a targeted #ProstateCancer screening approach using polygenic risk scores derived from 130 known genetic variants, identifying men aged 55–69 in

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer (BARCODE1) out on NEJM 

nejm.org/doi/full/10.10…

Study evaluated a targeted #ProstateCancer screening approach using polygenic risk scores derived from 130 known genetic variants, identifying men aged 55–69 in